BONDURANT STUART 4
4 · Furiex Pharmaceuticals, Inc. · Filed May 12, 2011
Insider Transaction Report
Form 4
BONDURANT STUART
Director
Transactions
- Purchase
Common Stock
2011-05-11$15.25/sh+3,300$50,324→ 3,896 total
Holdings
- 17,570
Stock Options (to buy)
Exercise: $9.11Exp: 2020-06-17→ Common Stock (17,570 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.24 to $15.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.